Bestätigen Sie die Produktvariante
Fordern Sie das genaue Rejuran Program-Produkt, die Verpackung, den vorgesehenen Bereich und den Grund für die Betrachtung dieser Variante an.
Vorbereiten Sie die Produktfrage
PN · Produktvariante · Sitzungen · Erholung · Angebot
Rejuran Program
bestätigen Sie das Produkt vor der Planung.
Rejuran Program is a product family, not one universal protocol. Confirm the exact variant, purpose, area, session plan, recovery and current itemised quotation with a physician.
- Ausgangspunkt
- PN-Zusammensetzung
- Erholung / Zeitplan
- Die genaue Variante ist entscheidend
- Plan
- Sitzungen nach Beurteilung
- Preis / Nächster Schritt
- Erholung + Nachsorgeplan
Direkte Antwort
Was ist ein Rejuran Program, und was sollten wir vor der Behandlung bestätigen?
The manufacturer lists Rejuran Program as a PN (polynucleotide) medical device intended for temporary improvement of facial wrinkles.
Product variants and intended areas differ.
A physician should verify the exact product, local indication, treatment area, technique, medical history, session plan, risks, aftercare and follow-up before recommending treatment.
General information only. It is not a diagnosis or a treatment recommendation. Individual suitability and response vary.
- Manufacturer country
- South Korea
Product identity
Confirm the exact Rejuran Program product before comparing a plan.
The manufacturer lists several PN products with different packing units and compositions. Local registration and the product actually stocked still need confirmation.
- Rejuran Program
Base product · 2 cc syringe
The official page lists PN composition, 2 cc per syringe and two syringes per pack, with temporary improvement of facial wrinkles as the stated purpose.
- Rejuran Program i
Smaller 1 cc presentation
The manufacturer lists a 1 cc syringe and names the eye and perioral areas among several intended areas. This does not make every thin-skin concern suitable.
- Rejuran Program s
Separate 1 cc product
The official page lists PN composition and a 1 cc syringe. Confirm why this exact product, and not only the Rejuran Program brand name, is proposed.
- HB plus
1 mL syringe with PN + sodium hyaluronate + lidocaine
The official page lists a 1 mL syringe. HB plus is not the same formulation as base Rejuran Program, so confirm the exact box, ingredients, locally applicable use, allergy history and storage traceability.
Evidence quality
A retracted paper is not used to set expectations or sessions.
PubMed marks a commonly cited 2014 Rejuran Program paper as a retracted publication. This page keeps that status visible instead of repeating its protocol as clinical guidance.
- Status
The 2014 paper is retracted
Its participant count, treatment schedule, outcomes and safety conclusions are not used here to recommend treatment or predict results.
- What remains usable
Official pages support product identity
The manufacturer pages can support the displayed product names, packing units, listed compositions, storage information and stated intended purposes.
- What remains unknown
They do not establish an individual protocol
A product listing cannot decide suitability, area, amount, delivery method, number of sessions, recovery or response for a person.
- Page rule
No fixed session count from the archive
The old WordPress copy and retracted study are excluded from session and outcome claims. The written plan must come from current product verification and physician assessment.
Consultation sequence
Build the plan from the concern, not from a package count.
The number of syringes or sessions cannot safely be selected before the product, area, history, recovery window and review point are documented.
- 01
Name the concern and area
Separate wrinkle, texture, scar, dryness and volume questions. Similar-looking concerns may require different products or no injectable treatment.
- 02
Verify the box and variant
Record the exact product name, packing unit, batch traceability and why its locally applicable purpose fits the proposed area.
- 03
Review history and trade-offs
Discuss allergies, active skin problems, medicines, pregnancy or breastfeeding, previous injectables, pain and recovery constraints, plus reasonable alternatives.
- 04
Document one itemised plan
The written plan should state product, amount or syringe basis, area, sessions, aftercare, review point, escalation contact and current itemised quotation.
Beginnen Sie mit dem genauen Produkt, dem Zweck und der Hautfrage.
A brand name alone does not establish the variant, area, session count or suitability.
Medizinische und Behandlungsverlauf teilen
Allergien, Schwangerschaft oder Stillzeit, aktive Hautprobleme, Medikamente und vorherige Injektionen oder Reaktionen melden.
Relevanten Verlauf hinzufügenSitzungen und Erholung planen
Überprüfungspunkt bestätigen, erwartete kurzfristige Reaktionen, schriftliche Nachsorge und wie die Klinik zu erreichen ist, wenn Symptome sich verschlimmern.
Beratung startenPatient review and before-and-after images
Rejuran Program review and before-and-after images
Published with patient consent
This review gallery documents individual patients with before-and-after images and does not predict another person's outcome.
Case 01
- Documented interval
- 14 days
The image identifies the Program, but does not by itself establish the exact product variant, amount, treatment area, technique or complete treatment plan.
Individual results vary. Capture timing, lighting, expression, camera distance and angle may differ as part of real-world clinical photography. A physician consultation is required before treatment.
Fragen
Wie viele Rejuran Program Sitzungen benötige ich?
Es gibt keine sichere universelle Anzahl online. Der Arzt bestätigt das genaue Produkt, Anliegen, Bereich, Reaktion und Überprüfungspunkt vor Empfehlung eines Sitzungsplans.
Was ist der aktuelle Rejuran Program Preis?
Aktuelle detaillierten Angebot anfordern, das genaues Produkt, Spritze oder Sitzungsbasis, Bereich, Arztprozess, Nachsorge und Follow-up nennt. Diese Seite wiederholt keine unbestätigte Promotion.
Welche Reaktionen sollte ich besprechen?
Ask about product-specific risks and common injection reactions such as redness, swelling, bruising or tenderness, plus infection risk and the direct route for unusual, severe or worsening symptoms.
Ist jedes Rejuran Program Produkt gleich?
No. The manufacturer publishes different Rejuran Program variants and packing units. Confirm the exact product and locally applicable intended use before treatment.
Why does this page not use the commonly cited 2014 Rejuran Program study to recommend sessions?
PubMed marks that paper as a retracted publication. Its protocol and outcome claims are therefore not used to recommend a session count or predict results. This page relies on current manufacturer information for product identity and requires an individual physician assessment for the plan.
Offizielle PharmaResearch Rejuran Program Produktinformationen
Offizielle PharmaResearch Rejuran Program ProduktinformationenOfficial Rejuran Program product-family listOfficial Rejuran Program i product informationOfficial Rejuran Program s product informationOfficial Rejuran Program HB plus product informationPubMed record marking a commonly cited 2014 Rejuran Program paper as retractedPubMed retraction notice for the 2014 Rejuran Program paperOffizielle Klinik- und Kontaktinformationen
Wählen Sie, wie Sie uns erreichen.
Nutzen Sie den Kanal, der für die Terminkoordination und allgemeine Fragen am besten geeignet ist.
Messaging is not monitored as an emergency service. Language availability and response times can vary.